Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure

Pana, Tiberiu A., Mohamed, Mohamed O., Clark, Allan B., Fahy, Eoin, Mamas, Mamas A. and Myint, Phyo K. (2020) Revascularisation therapies improve the outcomes of ischemic stroke patients with atrial fibrillation and heart failure. International Journal of Cardiology. ISSN 0167-5273

[img] PDF (Accepted_Manuscript) - Submitted Version
Restricted to Repository staff only until 3 October 2021.

Download (6MB) | Request a copy

Abstract

Background Atrial fibrillation (AF) and heart failure (HF) carry a poor prognosis in acute ischaemic stroke (AIS). The impact of revascularisation therapies on outcomes in these patients is not fully understood. Method National Inpatient Sample (NIS) AIS admissions (January 2004–September 2015) were included (n = 4,597,428). Logistic regressions analysed the relationship between exposures (neither AF nor HF-reference, AF-only, HF-only, AF + HF) and outcomes (in-hospital mortality, length-of-stay >median and moderate-to-severe disability on discharge), stratifying by receipt of intravenous thrombolysis (IVT) or endovascular thrombectomy (ET). Results 69.2% patients had neither AF nor HF, 16.5% had AF-only, 7.5% had HF-only and 6.7% had AF + HF. 5.04% and 0.72% patients underwent IVT and/or ET, respectively. AF-only and HF-only were each associated with 75–85% increase in the odds of in-hospital mortality. AF + HF was associated with greater than two-fold increase in mortality. Patients with AF-only, HF-only or AF + HF undergoing IVT had better or at least similar in-hospital outcomes compared to their counterparts not undergoing IVT, except for prolonged hospitalisation. Patients undergoing ET with AF-only, HF-only or AF + HF had better (in-hospital mortality, discharge disability, all-cause bleeding) or at least similar (length-of-stay) outcomes to their counterparts not undergoing ET. Compared to AIS patients without AF, AF patients had approximately 50% and more than two-fold increases in the likelihood of receiving IVT or ET, respectively. Conclusions We confirmed the combined and individual impact of co-existing AF or HF on important patient-related outcomes. Revascularisation therapies improve these outcomes significantly in patients with these comorbidities.

Item Type: Article
Uncontrolled Keywords: atrial fibrillation,cerebrovascular disease,heart failure,stroke,thrombectomy,thrombolysis,cardiology and cardiovascular medicine ,/dk/atira/pure/subjectarea/asjc/2700/2705
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 06 Oct 2020 23:59
Last Modified: 21 Oct 2020 23:55
URI: https://ueaeprints.uea.ac.uk/id/eprint/77152
DOI: 10.1016/j.ijcard.2020.09.076

Actions (login required)

View Item View Item